Untreatable tuberculosis: is surgery the answer?

According to the 2014 World Health Organization (WHO) Global Report, tuberculosis (TB) continues to be the most important infectious disease in terms of incidence and mortality, along with HIV/AIDS: 9 million new cases and 1.5 million deaths are estimated to have occurred in 2013 [1]. No TB elimination is possible till the prevalence of drug-resistant TB is lowered at the global level http://ow.ly/GgUNg

[1]  G. Sotgiu,et al.  Facing multi-drug resistant tuberculosis. , 2015, Pulmonary pharmacology & therapeutics.

[2]  M. Dara,et al.  Consolidated Action Plan to Prevent and Combat Multidrug- and Extensively Drug-resistant Tuberculosis in the WHO European Region 2011-2015: Cost-effectiveness analysis. , 2015, Tuberculosis.

[3]  Francesco Castelli,et al.  Towards tuberculosis elimination: an action framework for low-incidence countries , 2015, European Respiratory Journal.

[4]  F. Blasi,et al.  Ensuring rational introduction and responsible use of new TB tools: outcome of an ERS multisector consultation , 2014, European Respiratory Journal.

[5]  G. Bloemberg,et al.  A mutation associated with clofazimine and bedaquiline cross-resistance in MDR-TB following bedaquiline treatment , 2014, European Respiratory Journal.

[6]  K. Floyd,et al.  Multidrug-resistant tuberculosis around the world: what progress has been made? , 2014, European Respiratory Journal.

[7]  Eduardo Gotuzzo,et al.  Multidrug-resistant tuberculosis and culture conversion with bedaquiline. , 2014, The New England journal of medicine.

[8]  A. Benedetti,et al.  Evidence-based, agreed-upon health priorities to remedy the tuberculosis patient's economic disaster , 2014, European Respiratory Journal.

[9]  M. Raviglione,et al.  Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review , 2014, European Respiratory Journal.

[10]  A. Spanevello,et al.  Tuberculosis elimination: theory and practice in Europe , 2014, European Respiratory Journal.

[11]  R. Diel,et al.  Costs of tuberculosis disease in the European Union: a systematic analysis and cost calculation , 2013, European Respiratory Journal.

[12]  A. Spanevello,et al.  Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence , 2013, European Respiratory Journal.

[13]  C. Dye,et al.  Prospects for tuberculosis elimination. , 2013, Annual review of public health.

[14]  Marieke J. van der Werf,et al.  Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination , 2013, European Respiratory Journal.

[15]  T. Holtz,et al.  Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes , 2012, European Respiratory Journal.

[16]  V. Leimane,et al.  Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis , 2012, European Respiratory Journal.

[17]  Giovanni Sotgiu,et al.  Efficacy and safety of meropenem–clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB , 2012, European Respiratory Journal.

[18]  G. Sotgiu,et al.  Treatment of tuberculosis: have we turned the corner? , 2012, The Lancet.

[19]  Marcos Burgos,et al.  Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients , 2012, PLoS medicine.

[20]  T. Shim,et al.  Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis , 2012, European Respiratory Journal.

[21]  K. Kliiman,et al.  TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged? , 2012, European Respiratory Journal.

[22]  A. Skrahina,et al.  Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk , 2011, European Respiratory Journal.

[23]  H. Schünemann,et al.  The 2011 update of the World Health Organization guidelines for the programmatic management of drug-resistant tuberculosis , 2011 .

[24]  M. Raviglione,et al.  Preventing and managing antimicrobial resistance: imperative for chest physicians , 2011, European Respiratory Journal.

[25]  C. Dye.  Global epidemiology of tuberculosis , 2006, The Lancet.

[26]  Y. Amdekar,et al.  Multidrug resistant tuberculosis. , 1998, Indian pediatrics.

[27]  THE WORLD HEALTH ORGANIZATION , 1954 .

[28]  L. Gabbasova,et al.  Global tuberculosis report (2014) , 2014 .

[29]  V. Venkataramanan,et al.  Surgical interventions for drug-resistant tuberculosis: a systematic review and meta-analysis. , 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.